Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vanish XT Extended Contact Varnish is a light-curable, resin-modified glass ionomer (RMGI) varnish designed for site-specific enamel and dentin protection. Developed by 3M ESPE (now Solventum), it is used to treat tooth hypersensitivity, prevent demineralization, and manage white spot lesions (WSLs), particularly in orthodontic patients. The product contains fluoroaluminosilicate glass, which facilitates the sustained release of fluoride, calcium, and phosphate ions to promote remineralization of the tooth structure. Upon application, it forms a durable physical barrier that penetrates and seals dentin tubules, providing extended protection for high-risk surfaces such as newly erupted teeth and areas around orthodontic brackets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vanish XT Extended Contact Varnish.